Non-alcoholic fatty liver disease (NAFLD) is characterised by excess lipids in hepatocytes due to an overload of fatty acid influx from adipose tissue, as well as the consumption of too many dietary fats and carbohydrates.
Silymarin and silibinin, caffeine, bioflavonoids, curcumin, resveratrol and other natural polyphenols have been found beneficial for NAFLD in studies and preclinical trials.
Practitioners looking for a therapeutic edge when tailoring detoxification protocols for patients would be wise to consider phosphatidyl choline – a vital nutrient with surprising benefits.
Coffee is one of the most consumed beverages worldwide, with epidemiologic studies showing a link between coffee consumption and lower levels of liver disease and all-cause mortality.
Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease in Australia. There is increasing evidence for considering NAFLD as part of metabolic syndrome including obesity, hyperinsulinaemia, insulin resistance, hypertriglyceridaemia and hypertension.